Take­da bets $100M up­front on AC Im­mune's an­ti-amy­loid Alzheimer's vac­cine

AC Im­mune has lined up its third phar­ma part­ner in Alzheimer’s dis­ease, and the pact comes with a hefty biobucks pack­age.

Take­da will pay AC …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.